Casavatore

Researchers are conducting a multicenter observational study to collect and analyze data from cancer patients registered in the ROC platform in the Campania region. This study aims to create a combined retrospective and prospective registry to better understand cancer patient outcomes and healthcare processes in this region, which has worse oncological outcomes compared to other Italian regions. The study hopes to use this large, representative dataset to guide decision-making and improve cancer care. The study involves collecting patient data retrospectively from the start of the ROC platform in November 2018 up to the ethics committee approval date, and prospectively from the approval date onward. All ROC centers participate, and the data collection focuses on patients entering the ROC platform and following a GOM path. There is no experimental treatment; rather, the study monitors data and performance related to the ROC platform's use and cancer patient management. Participants will have their data analyzed regularly over several years, with outcomes measured including tumor incidence and prevalence, timing and frequency of medical activities, adherence to guidelines, clinical trial participation, and healthcare costs. Data will be reviewed every 2 to 6 months up to 5 years depending on the outcome. This long-term follow-up aims to assess the effectiveness of public oncology interventions and improve care coordination.